Theravance Biopharma Cash from Financing (TTM) Trends

Theravance Biopharma Inc (TBPH)

9.46 +0.12 (+1.28%) USD | NASDAQ | Apr 22, 16:00

9.46 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	-198.93M
September 30, 2023	-203.80M
June 30, 2023	-894.42M
March 31, 2023	-813.60M
December 31, 2022	-758.81M
September 30, 2022	-723.18M
June 30, 2022	-3.445M
March 31, 2022	101.70M
December 31, 2021	91.86M
September 30, 2021	92.45M
June 30, 2021	93.78M
March 31, 2021	-9.635M
December 31, 2020	263.08M
September 30, 2020	260.80M
June 30, 2020	261.63M
March 31, 2020	264.16M
December 31, 2019	1.291M
September 30, 2019	232.44M
June 30, 2019	232.25M
March 31, 2019	225.45M
December 31, 2018	225.20M

Date	Value
September 30, 2018	-3.773M
June 30, 2018	-4.24M
March 31, 2018	1.192M
December 31, 2017	1.656M
September 30, 2017	333.48M
June 30, 2017	334.75M
March 31, 2017	451.99M
December 31, 2016	479.23M
September 30, 2016	200.61M
June 30, 2016	200.05M
March 31, 2016	81.29M
December 31, 2015	81.31M
September 30, 2015	27.31M
June 30, 2015	27.65M
March 31, 2015	350.25M
December 31, 2014	370.62M
September 30, 2014	407.03M
June 30, 2014	439.94M
March 31, 2014	140.88M
December 31, 2013	123.59M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-894.42M

Minimum

Jun 2023

264.16M

Maximum

Mar 2020

-90.02M

Average

91.86M

Median

Dec 2021

Cash from Financing (TTM) Benchmarks